Stay updated with breaking news from Ongoing Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
— Complete data from Phase 1A clinical trial of SL-172154 as monotherapy in platinum-resistant ovarian cancer to be presented at the 2023 American Society of Clinical Oncology annual meeting... | May 9, 2023
Continued progress across pipeline, including encouraging BT8009 Phase I dose escalation results presented in Q1'23 Entered into a strategic collaboration with Novartis and expanded separate collaboration
Continued to Advance Monotherapy Dose Escalation Stage of Ongoing Phase 1/2 MYCHELANGELO™ I Study; Preliminary Data Anticipated in 2023Announced Clinical Supply Agreement with Roche to Evaluate... | May 4, 2023
A major obstacle to the treatment of glioblastoma, a deadly brain tumor, is the inability of the most potent chemotherapy to cross the blood-brain barrier to reach aggressive brain tumors. But now, scientists at Northwestern Medicine are using a novel ultrasound device that can be implanted in the skull to open the blood-brain barrier […]
Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to... | April 12, 2023